Limosilactobacillus reuteri YLR001 Attenuates DSS-Induced Colitis in Association with Notch-Related Macrophage Polarization and the Gut Microbiota–Bile Acid Remodeling
Background: Inflammatory bowel disease (IBD) is characterized by impaired intestinal barrier function, dysregulated immune responses, and gut microbial imbalance. Although Limosilactobacillus reuteri exerts strain-dependent anti-inflammatory effects, the mechanisms linking its immunomodulatory activity to microbial and metabolic homeostasis remain unclear. Objective: This study investigated the protective effects of yak-derived Limosilactobacillus reuteri YLR001 against DSS-induced colitis, focusing on Notch-associated macrophage polarization and microbiota-related bile acid metabolism. Methods: DSS-induced colitis mice and LPS-stimulated RAW 264.7 macrophages were used to evaluate disease severity, epithelial barrier integrity, inflammatory responses, macrophage polarization, and Notch1/Jagged1/Hes1 signaling. DAPT, a γ-secretase inhibitor, was used as a pharmacological probe of Notch-associated responses. Gut microbiota and cecal metabolites were characterized by 16S rRNA sequencing and untargeted metabolomics, followed by microbiota–metabolite correlation analysis. Results: YLR001 alleviated body-weight loss, colonic shortening, disease activity, splenomegaly, and histological damage, while restoring ZO-1, Occludin, Claudin-1, and MUC2 expression. It suppressed the pro-inflammatory macrophage phenotype, reducing iNOS and increasing Arg-1, CD206, and CD163, accompanied by lower IL-1β, IL-6, and TNF-α and higher IL-10 levels. These changes coincided with reduced expression of Notch1, Jagged1, and Hes1, whereas DAPT elicited comparable macrophage responses. In addition, YLR001 partially restored microbial homeostasis and modulated bile acid-related metabolic pathways. Correlation analysis further associated responsive taxa and metabolites with epithelial barrier and inflammatory phenotypes. Conclusions: YLR001 attenuates experimental colitis with associated changes in macrophage responses and the intestinal microbial–metabolic environment, supporting its potential as a strain-specific probiotic candidate.
Authors
- Xiaofei Ma (ORCID: https://orcid.org/0009-0006-8969-0133)
- Huachun Pan (ORCID: https://orcid.org/0000-0002-4132-0946)
- Tian Niu (ORCID: https://orcid.org/0000-0002-6700-4538)
- Junjie Hu (ORCID: https://orcid.org/0000-0003-2522-4724)
- Tao Li (ORCID: https://orcid.org/0000-0002-4396-4390)
- Lihong Zhang (ORCID: https://orcid.org/0009-0007-5341-576X)
- Yuting Zou
- Jianchun Sun
- Zhenxing Yan
- Yue Gao
Institutions
- Gansu Agricultural University (CN)
- Longyan University (CN)
Publication Details
- Journal
- Foods
- Published
- 2026-11-18
- DOI
- https://doi.org/10.3390/foods15224143
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China